AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2017

Nov 29, 2017

30071_dirs_2017-11-28_5a19f9aa-9810-4ca6-8d67-2696d863101e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2017-11-27

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-27	ResMed Common Stock	A	27876	$84.63	Acquired	238941	Direct
2017-11-27	ResMed Common Stock	F	14546	$84.63	Disposed	224395	Direct

Footnotes

F1: Shares acquired on vesting of performance-based restricted stock units. The PSUs were granted November 19, 2014, with a three-year performance period. The shares were earned and vested November 27, 2017, when the ResMed compensation committee certified performance.

F2: Shares earned based on performance at 57% of the target award.

F3: Disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/19/2014.